Literature DB >> 19020786

Evaluation of urgency in women, with a validated Urgency, Severity and Impact Questionnaire (USIQ).

Lior Lowenstein1, Mary P FitzGerald, Kimberly Kenton, Lena Hatchett, Ramon Durazo-Arvizu, Elizabeth R Mueller, Kara Goldman, Linda Brubaker.   

Abstract

The objective of this study is to develop a validated, patient-oriented questionnaire to assess urgency and associated life impact. We interviewed six urogynecologists and urologists and five patients with overactive bladder (OAB) symptoms about urinary urgency. Based on this data, we composed the first draft of our Urgency Severity and Impact Questionnaire (USIQ). A focus group of OAB patients provided feedback on the USIQ draft. The revised questionnaire has two parts: symptom severity (USIQ-S) and related quality of life (USIQ-QOL). The questionnaire was given to patients with clinically diagnosed OAB to establish face, content and discriminatory validity. Cronbach's alpha for the USIQ-S and USIQ-QOL were 0.85 and 0.90, respectively. USIQ-QOL was moderately correlated with UDI-6 (r = 0.49, p < 0.001), IIQ-7 (r = 0.77, p < 0.001), and OAB-q (r = 0.73, p < 0.001). Mean USIQ-QOL and USIQ-S scores differed by clinical diagnosis. The USIQ is an easily understood questionnaire with adequate validity for use in clinical practice and research.

Entities:  

Mesh:

Year:  2008        PMID: 19020786     DOI: 10.1007/s00192-008-0770-0

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  9 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  The urgency perception score: validation and test-retest.

Authors:  Jerry G Blaivas; Georgia Panagopoulos; Jeffrey P Weiss; Chandra Somaroo; David C Chaikin
Journal:  J Urol       Date:  2007-01       Impact factor: 7.450

3.  Two-year incidence, remission, and change patterns of urinary incontinence in noninstitutionalized older adults.

Authors:  A R Herzog; A C Diokno; M B Brown; D P Normolle; B M Brock
Journal:  J Gerontol       Date:  1990-03

4.  A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials.

Authors:  Annabel Nixon; Shoshana Colman; Luann Sabounjian; Bobby Sandage; Ute E Schwiderski; David R Staskin; Norman Zinner
Journal:  J Urol       Date:  2005-08       Impact factor: 7.450

5.  Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score.

Authors:  Yukio Homma; Masaki Yoshida; Narihito Seki; Osamu Yokoyama; Hidehiro Kakizaki; Momokazu Gotoh; Tomonori Yamanishi; Osamu Yamaguchi; Masayuki Takeda; Osamu Nishizawa
Journal:  Urology       Date:  2006-08       Impact factor: 2.649

6.  Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).

Authors:  Louis S Matza; Christine L Thompson; Joel Krasnow; Jessica Brewster-Jordan; Teresa Zyczynski; Karin S Coyne
Journal:  Neurourol Urodyn       Date:  2005       Impact factor: 2.696

7.  A simple validated scale to measure urgency.

Authors:  Salah Al-Buheissi; Rajvinder Khasriya; Barry H Maraj; James Malone-Lee
Journal:  J Urol       Date:  2008-01-18       Impact factor: 7.450

8.  Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q.

Authors:  K Coyne; D Revicki; T Hunt; R Corey; W Stewart; J Bentkover; H Kurth; P Abrams
Journal:  Qual Life Res       Date:  2002-09       Impact factor: 4.147

9.  Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group.

Authors:  J S Uebersax; J F Wyman; S A Shumaker; D K McClish; J A Fantl
Journal:  Neurourol Urodyn       Date:  1995       Impact factor: 2.696

  9 in total
  6 in total

1.  Efficacy of capacitive resistive monopolar radiofrequency in the physiotherapeutic treatment of chronic pelvic pain syndrome: study protocol for a randomized controlled trial.

Authors:  A Carralero-Martínez; M A Muñoz Pérez; R Pané-Alemany; L Blanco-Ratto; S Kauffmann; I Ramírez-García
Journal:  Trials       Date:  2021-05-20       Impact factor: 2.279

2.  Reliability and responsiveness of the Urgency Severity and Life Impact Questionnaire (USIQ).

Authors:  Lior Lowenstein; Leslie Rickey; Kimberly Kenton; Mary P Fitzgerald; Linda Brubaker; Mary Tulke; Joye Fordham; Elizabeth R Mueller
Journal:  Int Urogynecol J       Date:  2011-08-18       Impact factor: 2.894

3.  Development and psychometric evaluation of the urgency questionnaire for evaluating severity and health-related quality of life impact of urinary urgency in overactive bladder.

Authors:  Karin S Coyne; Chris C Sexton; Christine Thompson; Tamara Bavendam; Linda Brubaker
Journal:  Int Urogynecol J       Date:  2014-06-19       Impact factor: 2.894

Review 4.  New Insights about Chronic Pelvic Pain Syndrome (CPPS).

Authors:  Keren Grinberg; Yael Sela; Rachel Nissanholtz-Gannot
Journal:  Int J Environ Res Public Health       Date:  2020-04-26       Impact factor: 3.390

5.  How Does Myofascial Physical Therapy Attenuate Pain in Chronic Pelvic Pain Syndrome?

Authors:  Keren Grinberg; Irit Weissman-Fogel; Lior Lowenstein; Liora Abramov; Michal Granot
Journal:  Pain Res Manag       Date:  2019-12-12       Impact factor: 3.037

6.  A Randomized Trial of Modified-Release Versus Immediate-Release Tolvaptan in ADPKD.

Authors:  Ronald D Perrone; Arlene B Chapman; Dorothee Oberdhan; Frank S Czerwiec; Olga Sergeyeva; John Ouyang; Susan E Shoaf
Journal:  Kidney Int Rep       Date:  2020-03-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.